Medicine
Cyproheptadine 2 mg tablet
Cyproheptadine 2 mg tablet is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Cyproheptadine
- Brand
- Sold under the generic name
- Strength
- 2 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 60 tablets and 1 more
- Manufacturers
- Pangea PharmaceuticalsQuagen Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- R06AX02 Cyproheptadine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 12 October 2026
- Identifiers
- RxCUI 2754679DailyMed set ID e6d91eae-db29-4e62-89da-1ad764de7ae1, 2851bd5c-fcc8-4a7a-9be3-950ea799dee1NDC 70752-232, 81279-129Application ANDA212491
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle, plastic | 81279-129-30 | Pangea Pharmaceuticals | 12 October 2026 |
| 60 tablet in 1 bottle, plastic | 81279-129-60 | Pangea Pharmaceuticals | 12 October 2026 |
| 30 tablet in 1 bottle | 70752-232-03 | Quagen Pharmaceuticals | 15 October 2026 |
| 60 tablet in 1 bottle | 70752-232-05 | Quagen Pharmaceuticals | 15 October 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 17 October 1961 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cyproheptadine
Clinical summary
Cyproheptadine is a prescription medicine. It is available as tablets, oral solution and syrup. MedsAcross supplies Cyproheptadine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CyproheptadineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CYPROHEPTADINE HYDROCHLORIDE prescribing information (Pangea Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Cyproheptadine 2 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.